A Comparison of Five Different Treatment Regimens as the First-Line Treatment of Helicobacter pylori in Turkey

Basit Öğe Kaydı
dc.contributor.authorUnler, Gulhan Kanat
dc.contributor.authorOzgur, Gulsum Teke
dc.contributor.authorGokturk, Huseyin Savas
dc.contributor.authorKarakoca, Aydin
dc.contributor.authorErinanc, Ozgur Hilal
dc.date.accessioned2024-02-23T14:24:15Z
dc.date.available2024-02-23T14:24:15Z
dc.date.issued2016
dc.departmentNEÜen_US
dc.description.abstractBackgroundThe H. pylori eradication success is low in countries with high antibiotic resistance to H. pylori. ObjectiveWe retrospectively assessed the eradication rates achieved by five different regimens and aimed to compare the efficiency of bismuth enhanced sequential therapy and other treatments in a gastroenterology outpatient clinic a university-affiliated hospital. DesignOur study was carried out with a retrospective cohort design. SettingThis study assessed the gastroscopy examinations of patients. PatientsA total of 621 patients were included in the study. There were 122 patients in the quadruple treatment group, 168 patients in the classical sequential treatment group, 130 patients in the bismuth enhanced sequential therapy, 113 patients in the sequential treatment with levofloxacin, and 88 patients in the hybrid treatment. MeasurementsEradication rates of different regimens was analyzed by performing Chi-square and Tukey's honest significant difference test. ResultsEradication rates by ITT and PP analysis achieved by treatment groups were 74.6 and 75.6% in the quadruple treatment; 70.2 and 70.4% in the sequential treatment with clarithromycin, 88.5 and 90.3% in the bismuth enhanced sequential therapy, 77.9 and 78.5% in the sequential treatment with levofloxacin, and 76.1 and 76.2% in the hybrid treatment. LimitationsThe main limitation of our study was its retrospective nature. Different proton pump inhibitors were used in the treatment arms. ConclusionsBismuth-enhanced sequential therapy can be recommended to overcome resistance.en_US
dc.identifier.doi10.1111/hel.12285
dc.identifier.endpage285en_US
dc.identifier.issn1083-4389
dc.identifier.issn1523-5378
dc.identifier.issue4en_US
dc.identifier.pmid26621567en_US
dc.identifier.scopus2-s2.0-84978149960en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage279en_US
dc.identifier.urihttps://doi.org/10.1111/hel.12285
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13858
dc.identifier.volume21en_US
dc.identifier.wosWOS:000380269000004en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofHelicobacteren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEradication Therapyen_US
dc.subjectHelicobacter Pylorien_US
dc.subjectBismuthen_US
dc.titleA Comparison of Five Different Treatment Regimens as the First-Line Treatment of Helicobacter pylori in Turkeyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu